Experience in treating disseminated breast cancer after multimodality therapy
Median survival in patients with disseminated breast cancer (BC) is less than 3 years; moreover, 25-30 and 10% survive > 5 and > 10 years, respectively. Current systemic therapy increases median survival rates by only 3-4 months as compared with patients who do not receive this therapy...
Main Authors: | G. A. Khakimov, N. R. Shayusupov, G. F. Miryusupova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/208 |
Similar Items
-
Outcomes of Adult Ewing Sarcoma Treated with Multimodality Therapy: A Single-Institute Experience
by: Ravi Chandran, et al.
Published: (2020-10-01) -
EXPERIENCE IN TREATING PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
by: G. A. Khakimov, et al.
Published: (2014-09-01) -
MULTIMODALITY TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BREAST CANCER INCLUDING NEUTRON THERAPY DELIVERED TO THE POSTOPERATIVE CICATRIX
by: V. V. Velikaya, et al.
Published: (2016-02-01) -
Local dissemination of osteosarcoma observed after massage therapy: a case report
by: Shinji Miwa, et al.
Published: (2019-10-01) -
Current perspectives concerning the multimodal therapy in Glioblastoma
by: Florina Grigore, et al.
Published: (2015-03-01)